DexCom Price to Free Cash Flow Ratio 2010-2025 | DXCM
Historical price to free cash flow ratio values for DexCom (DXCM) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| DexCom Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-20 | 87.34 | 62.38 | |
| 2025-03-31 | 68.29 | $1.40 | 48.77 |
| 2024-12-31 | 77.77 | $1.53 | 50.89 |
| 2024-09-30 | 67.04 | $1.30 | 51.56 |
| 2024-06-30 | 113.38 | $1.59 | 71.35 |
| 2024-03-31 | 138.70 | $1.38 | 100.81 |
| 2023-12-31 | 124.09 | $1.20 | 103.14 |
| 2023-09-30 | 93.30 | $1.17 | 79.84 |
| 2023-06-30 | 128.51 | $1.08 | 118.58 |
| 2023-03-31 | 116.18 | $0.98 | 118.29 |
| 2022-12-31 | 113.24 | $0.71 | 158.89 |
| 2022-09-30 | 80.54 | $6.83 | 11.79 |
| 2022-06-30 | 74.53 | $6.72 | 11.08 |
| 2022-03-31 | 127.90 | $6.44 | 19.87 |
| 2021-12-31 | 134.24 | $6.34 | 21.17 |
| 2021-09-30 | 136.72 | $0.31 | 443.59 |
| 2021-06-30 | 106.75 | $0.23 | 463.53 |
| 2021-03-31 | 89.85 | $0.57 | 157.82 |
| 2020-12-31 | 92.43 | $0.66 | 140.49 |
| 2020-09-30 | 103.06 | $0.68 | 150.65 |
| 2020-06-30 | 101.35 | $0.56 | 181.63 |
| 2020-03-31 | 67.32 | $0.36 | 188.46 |
| 2019-12-31 | 54.69 | $0.36 | 150.11 |
| 2019-09-30 | 37.31 | $0.14 | 262.19 |
| 2019-06-30 | 37.46 | $0.11 | 334.76 |
| 2019-03-31 | 29.78 | $0.15 | 196.41 |
| 2018-12-31 | 29.95 | $0.16 | 188.36 |
| 2018-09-30 | 35.76 | $0.18 | 199.33 |
| 2018-06-30 | 23.75 | $0.15 | 154.89 |
| 2018-03-31 | 18.54 | $0.07 | 254.32 |
| 2017-12-31 | 14.35 | $0.08 | 190.54 |
| 2017-09-30 | 12.23 | $-0.01 | 0.00 |
| 2017-06-30 | 18.29 | $-0.05 | 0.00 |
| 2017-03-31 | 21.18 | $-0.03 | 0.00 |
| 2016-12-31 | 14.93 | $0.00 | 0.00 |
| 2016-09-30 | 21.92 | $0.01 | 1588.04 |
| 2016-06-30 | 19.83 | $0.03 | 774.71 |
| 2016-03-31 | 16.98 | $0.03 | 597.80 |
| 2015-12-31 | 20.48 | $0.05 | 416.16 |
| 2015-09-30 | 21.47 | $0.06 | 343.44 |
| 2015-06-30 | 20.00 | $0.06 | 360.27 |
| 2015-03-31 | 15.59 | $0.03 | 497.92 |
| 2014-12-31 | 13.76 | $0.02 | 559.45 |
| 2014-09-30 | 10.00 | $0.02 | 523.43 |
| 2014-06-30 | 9.92 | $-0.01 | 0.00 |
| 2014-03-31 | 10.34 | $-0.02 | 0.00 |
| 2013-12-31 | 8.85 | $-0.02 | 0.00 |
| 2013-09-30 | 7.06 | $-0.07 | 0.00 |
| 2013-06-30 | 5.61 | $-0.10 | 0.00 |
| 2013-03-31 | 4.18 | $-0.13 | 0.00 |
| 2012-12-31 | 3.40 | $-0.16 | 0.00 |
| 2012-09-30 | 3.76 | $-0.17 | 0.00 |
| 2012-06-30 | 3.24 | $-0.17 | 0.00 |
| 2012-03-31 | 2.61 | $-0.15 | 0.00 |
| 2011-12-31 | 2.33 | $-0.15 | 0.00 |
| 2011-09-30 | 3.00 | $-0.16 | 0.00 |
| 2011-06-30 | 3.62 | $-0.18 | 0.00 |
| 2011-03-31 | 3.88 | $-0.21 | 0.00 |
| 2010-12-31 | 3.41 | $-0.22 | 0.00 |
| 2010-09-30 | 3.31 | $-0.20 | 0.00 |
| 2010-06-30 | 2.89 | $-0.21 | 0.00 |
| 2010-03-31 | 2.44 | $-0.23 | 0.00 |
| 2009-12-31 | 2.02 | $-0.24 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $34.098B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.298B | 88.17 |
| Thermo Fisher Scientific (TMO) | United States | $156.252B | 18.90 |
| Edwards Lifesciences (EW) | United States | $45.778B | 30.01 |
| Alcon (ALC) | Switzerland | $44.076B | 29.79 |
| IDEXX Laboratories (IDXX) | United States | $41.955B | 48.21 |
| IQVIA Holdings (IQV) | United States | $24.832B | 13.91 |
| STERIS (STE) | Ireland | $24.813B | 27.36 |
| Mettler-Toledo (MTD) | United States | $24.089B | 28.65 |
| Waters (WAT) | United States | $21.336B | 30.10 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $12.575B | 13.66 |
| Penumbra (PEN) | United States | $10.904B | 85.58 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $8.397B | 19.69 |
| Teleflex (TFX) | United States | $5.662B | 9.35 |
| Glaukos (GKOS) | United States | $5.477B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.238B | 22.20 |
| TransMedics (TMDX) | United States | $4.130B | 89.78 |
| PROCEPT BioRobotics (PRCT) | United States | $3.280B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Veracyte (VCYT) | United States | $2.271B | 31.87 |
| Nihon Kohden (NHNKY) | Japan | $2.119B | 24.30 |
| Elekta AB (EKTAY) | Sweden | $2.079B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $1.905B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.514B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.053B | 5.60 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| IRadimed (IRMD) | United States | $0.689B | 34.97 |
| RxSight (RXST) | United States | $0.663B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.655B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| Delcath Systems (DCTH) | United States | $0.630B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.601B | 9.35 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.557B | 0.00 |
| AxoGen (AXGN) | United States | $0.536B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 12.84 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.218B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| EDAP TMS S.A (EDAP) | France | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |